CABA Cabaletta Bio, Inc.: institutional ownership and insider trading
150 funds reported holding $516M of Cabaletta Bio, Inc. in their latest 13F filings; in Q2 2026 funds net bought $235M, with 52 new positions and 22 funds selling out; over the last 12 months insiders bought $296K and sold $0 on the open market.
CABA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$51.0M, EPS -0.34
- Quarter ended Mar 31, 2026: revenue n/a, net income −$43.5M, EPS -0.39
- Quarter ended Dec 31, 2025: revenue n/a, net income −$41.9M, EPS -0.22
- Quarter ended Sep 30, 2025: revenue n/a, net income −$44.9M, EPS -0.44
Famous investors holding CABA
- Renaissance Technologies (Renaissance Technologies): $4.77M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $12.9M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.43M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.39M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $282K, 0.0% of the portfolio
Largest institutional holders of CABA
- JENNISON ASSOCIATES LLC — $62.3M
- T. Rowe Price Investment Management, Inc. — $58.7M
- Bain Capital Life Sciences Investors, LLC — $53.6M
- BlackRock, Inc. (BLK) — $33.4M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $28.5M
- STATE STREET CORP (STT, STT-PG) — $24.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $22.5M
- Cormorant Asset Management, LP — $15.6M
- PRICE T ROWE ASSOCIATES INC /MD/ — $13.7M
- Woodline Partners LP — $13.1M
Recent CABA insider trades
- Jan 21, 2026: Gavel Steve bought 22,170 shares ($50.3K)
- Jan 21, 2026: Bollard Catherine bought 4,405 shares ($10.00K)
- Jan 21, 2026: Nichtberger Steven bought 45,000 shares ($101K)
- Jan 21, 2026: Simon Mark bought 11,061 shares ($25.2K)
5%+ owners
- T. Rowe Price Investment Management, Inc.: 11.6% (Schedule 13G/A, filed Aug 14, 2026)
- Jennison Associates LLC: 11.4% (Schedule 13G/A, filed Jun 4, 2026)
- PRUDENTIAL FINANCIAL INC: 11.4% (Schedule 13G/A, filed Jun 5, 2026)
- Bain Capital Life Sciences Opportunities III, LP: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- Adage Capital Management, L.P.: 8.4% (Schedule 13G/A, filed Aug 12, 2026)
- Cormorant Asset Management, LP: 6.0% (Schedule 13G/A, filed Aug 14, 2026)
Who owns the most CABA stock?
The largest institutional holders of Cabaletta Bio, Inc. in the latest 13F filings are JENNISON ASSOCIATES LLC ($62.3M), T. Rowe Price Investment Management, Inc. ($58.7M), Bain Capital Life Sciences Investors, LLC ($53.6M).
Are insiders buying or selling CABA?
Over the last 12 months insiders bought $296K and sold $0 of Cabaletta Bio, Inc. stock on the open market (SEC Form 4).
Which famous investors own CABA?
Renaissance Technologies, Ken Griffin, Izzy Englander, Two Sigma, D. E. Shaw.
Which ETFs hold CABA?
5 ETFs and mutual funds hold it among their top 100 positions, including PHLAX, FBDIX, BRUSX, JMCGX.